Jiaju Xu - Publications

Correction: Converting an immunologically "cold" tumor: Exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma.

Journal: Frontiers in immunology

Published: June 01, 2026

Tislelizumab-induced distal renal tubular acidosis presenting with life-threatening hypokalemia: a case report.

Journal: Frontiers in immunology

Published: April 06, 2026

Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 05, 2026

Case Report: Converting an immunologically "cold" tumor: exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma.

Journal: Frontiers in immunology

Published: October 30, 2025

Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: a case report.

Journal: Frontiers in oncology

Published: May 29, 2024